Charles Koch: You can call me ‘liberal’...
In a candid, wide-ranging interview with Yahoo Finance Editor-in-Chief Andy Serwer, Charles Koch, Chairman and CEO of Koch Industries and author of the new book, Good Profit: How Creating Value for Others Built One of the World’s Most Successful Companies, calls himself a “classical liberal.” Surprised? There’s a simple explanation and Koch lays it out for Serwer, explaining why it would be just fine with him to be called “liberal.”
"Export all of them."
If US exported all of the Italians, Germans, and Japaneses because they were US enemies during the WWII... wondering how many Italians are still in the US today to post about "export all of them" on this MB..
Individualism is a moral, political or social outlook that stresses human independence and the importance of individual self-reliance and liberty. then why talk about collective punishment for any religions, race or group of refugees? ie: Mafia is an organized crime group, led by Italian men..
can you treat all Italian men as Mafia? childish argument... LMAO
Fraz, you need to give your acct #, and brokage firm for them to believe you.. otherwise, anyone can type up anything.. get it... LMAO..
EXEL up 37.9% pre-market.. let me put my reading glasses on..
OMG, it is down -3.79%.. what happen? after the FDA approval, stock drops!!!
same story with the MNKD and other small Biotechs.. small investors thoughts the FDA approval is the breakout that will make them millionaires..
Unfortunately, the clinical benefits may NOT be the financial success..
don't count your chickens before they hatch.. LMAO
after the HALT is lifted, EXEL up $.16 (+2.5%)...
WOW.. Fraz, you should be excited because MNKD is tanking fast.. LMAO..
At SITC, Celldex Therapeutics presented data for varlilumab, an antibody that binds and activates CD27, a protein that stimulates the immune system. While the data is interesting and suggests a mechanism of action for varlilumab, it's of the preclinical variety. No one gets a medal for curing a mouse of cancer -- especially when the scientist gave the mouse the cancer in the first place. LMAO
You are a legend in your own mind.... Mr. Fraz Jr.... always sold at the top prices eh??? LMAO
CLDX news were fantastic 6 mos ago, and stock price dropped 60%.. how in the world could anybody sold when it was $32.. stop making a fool of yourself... LMAO...
"as we prepare for potential product launches", CLDX management have shown zero result for increasing $10M G&A in 2015.
The reason they didn't file for the Rintega's AA because they have less than 50% chance of getting the AA (data wasn't good enough)... another BTD is being wasted by the incompetent management..
investors should look at the results, they have produced NOTHING, but they get higher salaries, bigger bonuses, huge stock options granted.... enough said...
Analysts and Biotech Experts insist that Data Is 'Fantastic' ,Bluebird Bio Selling 'An Overreaction,'
Apparently, experts don't follow the money.... LMAO....
hedgies pumped to get secondary funding so they can short this POS.. they are curing a lot of rats in the lab but nothing to show for in the clinical trials.. time is running out for this BS... management is looting investors by giving themselves huge promotions, bonuses and stock options granted before getting the first FDA approval. CLDX management knows they will never get their drugs on the market, and that is the reason why they didn't buy this stock at the open market..
it is insignificant "good" data if CLDX shows only one or two patients still alive after a long period of time (2+ years), "Luck" factor should be considered.. if CLDX can demonstrated their drugs prolong the live of the 90+% of the patients, then CLDX has "the good" to cure cancer.. no biotech company in existence has the ability to prove their drug is effective more than 30% of the patients, which is marginally above the SOC to get the FDA approval.
Without filing for the AA, ReAct data should be interpreted as less than 40% chance to be approved by the FDA when the final data is complete... GL...
why don't you take a look of how old the data is.. most of the institutional ownership data has not been updated for more than 9 months.. the new ownership is about 45 days old, have you heard about the HFT? nano second execution, not 45 days old data as a baseline..
if your investment is based on 45 days old data, or thinking SEC would enforce the wrong doing by the WS firms, then how old is your brain?... LMAO..
CLDX stock is down because of its science, money flow into stock is positive, great news on pre-clinical results, all publications are positive, no announcement of clinical failure, so many analysts raised PT above $40, Institutional ownership is over 90%, expecting AA announcement any day now.. high short interests is good for CLDX stock..investors need to be patience.. other than that, stock price is being manipulated by the hedge funds... lastly, I would blame HRC for the main reason for the CLDX stock price to drop... did I miss anything?
as a smart investor, my analyses focus on everything else other than the stock price.. wink.. wink... LMAO..
analysts SP targets are faked as well..this is a coordinated effort by hedgies to lure dump investors into this bio-scam.. there's no pipeline (only pipe dream), there's no cancer treatment (only treating rats in the lab), there's no investment (CLDX management doesn't believe in the company), there's no commercialization (FDA will never approve any of their "drug").. 80% drop in market caps, investors just wait and hope that company won't declare bankruptcy!!.. LMAO..
can't afford any more good news.. looks like upcoming updates were leaked.. long_vrts2 is trying to create smoke screen while institutions are exiting.. where are all the Fagotta BT longs today? LMAO
"t. davis was right on the money"? every biotech researcher over-inflating their claims of their research's potential and the implication of the financial success.. unfortunately,T. Davis's claims have NEVER been validated by an outside independent review board or the FDA.. So far, none of the pre-clinical study success have been granted AA by the FDA.. enuff said...
Until then, don't regurgitate 2 yrs old news like the new PR.. market caps has lost more than 70% for a reason..
CLDX can fool all the people some of the time, and some of the people all the time, but CLDX cannot fool all the people all the time.